{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:09:30Z","timestamp":1780924170043,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04230-x","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T21:05:01Z","timestamp":1744837501000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liquid formulations of Levothyroxine with ethanol or with parabens for treatment of congenital hypothyroidism: similar TSH and fT4 values in the first 6 months of follow up"],"prefix":"10.1007","volume":"89","author":[{"given":"Gaia","family":"Vincenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tarantola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Santagiuliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia Teresa","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Del Giacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Barera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Vigone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"2","key":"4230_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/thy.2020.0515","volume":"31","author":"EV Nagy","year":"2021","unstructured":"E.V. Nagy, P. Perros, E. Papini, M. Katko, L. Heged\u00fcs, New formulations of levothyroxine in the treatment of hypothyroidism: Trick or treat? Thyroid 31(2), 193\u2013201 (2021). https:\/\/doi.org\/10.1089\/thy.2020.0515.","journal-title":"Thyroid"},{"key":"4230_CR2","doi-asserted-by":"publisher","unstructured":"V. Rajkumar, Newer oral levothyroxine formulations: Is it time to switch over? Eur. Med. J., 40\u201346. (2023). https:\/\/doi.org\/10.33590\/emj\/10306765.https.","DOI":"10.33590\/emj\/10306765.https"},{"key":"4230_CR3","doi-asserted-by":"publisher","first-page":"621616","DOI":"10.3389\/fendo.2020.621616","volume":"11","author":"C Virili","year":"2021","unstructured":"C. Virili, N. Brusca, S. Capriello, M. Centanni, Levothyroxine therapy in gastric malabsorptive disorders. Front. Endocrinol. 11, 621616 (2021). https:\/\/doi.org\/10.3389\/fendo.2020.621616.","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4230_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1530\/eje-20-1444","volume":"186","author":"MC Vigone","year":"2021","unstructured":"M.C. Vigone, R. Ortolano, G. Vincenzi, C. Pozzi, M. Ratti, V. Assirelli, S. Vissani, P. Cavarzere, A. Mussa, R. Gastaldi, R. Di Mase, M. Salerno, M.E. Street, J. Trombatore, G. Weber, A. Cassio, Treatment of congenital hypothyroidism: Comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age. Eur. J. Endocrinol. 186(1), 45\u201352 (2021). https:\/\/doi.org\/10.1530\/eje-20-1444.","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4230_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-019-02049-x","volume":"66","author":"C Virili","year":"2019","unstructured":"C. Virili, P. Trimboli, M. Centanni, Novel thyroxine formulations: A further step toward precision medicine. Endocrine 66(1), 87\u201394 (2019). https:\/\/doi.org\/10.1007\/s12020-019-02049-x.","journal-title":"Endocrine"},{"issue":"5","key":"4230_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/MED.0000000000000558","volume":"27","author":"MJ Ritter","year":"2020","unstructured":"M.J. Ritter, S. Gupta, J.V. Hennessey, Alternative routes of levothyroxine administration for hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 27(5), 318\u2013322 (2020). https:\/\/doi.org\/10.1097\/MED.0000000000000558.","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"3","key":"4230_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/endrev\/bnac030","volume":"44","author":"H Liu","year":"2023","unstructured":"H. Liu, W. Li, W. Zhang, S. Sun, C. Chen, Levothyroxine: Conventional and novel drug delivery formulations. Endocr. Rev. 44(3), 393\u2013416 (2023). https:\/\/doi.org\/10.1210\/endrev\/bnac030.","journal-title":"Endocr. Rev."},{"issue":"6","key":"4230_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jpeds.2012.11.070","volume":"162","author":"A Cassio","year":"2013","unstructured":"A. Cassio, S. Monti, A. Rizzello, I. Bettocchi, F. Baronio, G. D\u2019Addabbo, M.O. Bal, A. Balsamo, Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J. Pediatrics 162(6), 1264\u20131269, 1269.e1-2 (2013). https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.070.","journal-title":"J. Pediatrics"},{"issue":"1","key":"4230_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000356047","volume":"81","author":"E Peroni","year":"2014","unstructured":"E. Peroni, M.C. Vigone, S. Mora, L.A. Bassi, C. Pozzi, A. Passoni, G. Weber, Congenital hypothyroidism treatment in infants: A comparative study between liquid and tablet formulations of levothyroxine. Hormone Res. Paediatrics 81(1), 50\u201354 (2014). https:\/\/doi.org\/10.1159\/000356047.","journal-title":"Hormone Res. Paediatrics"},{"issue":"9","key":"4230_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/children11091136","volume":"11","author":"R Ortolano","year":"2024","unstructured":"R. Ortolano, E. Cantarelli, F. Baronio, V. Assirelli, E. Candela, C. Mastrangelo, S. Vissani, R.S. Alqaisi, M. Lanari, A. Cassio, Comparison between liquid and tablet formulations in the treatment of congenital hypothyroidism up to 3 years of age: The first italian study. Children 11(9), 1136 (2024). https:\/\/doi.org\/10.3390\/children11091136.","journal-title":"Children"},{"issue":"1","key":"4230_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-14-211","volume":"14","author":"SM Ng","year":"2013","unstructured":"S.M. Ng, M.A. Turner, C. Gamble, M. Didi, S. Victor, D. Manning, P. Settle, R. Gupta, P. Newland, A.M. Weindling, An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks\u2019 gestation: Results of the TIPIT trial. Trials 14(1), 1 (2013). https:\/\/doi.org\/10.1186\/1745-6215-14-211.","journal-title":"Trials"},{"key":"4230_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1515\/jpem-2021-0458","volume":"35","author":"F Tzifi","year":"2021","unstructured":"F. Tzifi, A. Iliadi, A. Voutetakis, D. Platis, P. Girginoudis, C. Kanaka-Gantenbein, Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism. J. Pediatr. Endocrinol. Metab. 35, 239\u2013247 (2021). https:\/\/doi.org\/10.1515\/jpem-2021-0458.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"April","key":"4230_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.860775","volume":"13","author":"G Tuli","year":"2022","unstructured":"G. Tuli, J. Munarin, L. de Sanctis, Comparison among two liquid formulations of L-thyroxine in the treatment of congenital hypothyroidism in the first month of life: a pilot study. Front. Endocrinol. 13(April), 1\u20135 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.860775.","journal-title":"Front. Endocrinol."},{"issue":"6","key":"4230_CR14","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1542\/peds.2008-0027","volume":"123","author":"JE Donovan","year":"2009","unstructured":"J.E. Donovan, Estimated blood alcohol concentrations for child and adolescent drinking and their implications for screening instruments. Pediatrics 123(6), e975\u2013e981 (2009). https:\/\/doi.org\/10.1542\/peds.2008-0027.","journal-title":"Pediatrics"},{"issue":"1","key":"4230_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jat.958","volume":"24","author":"PD Darbre","year":"2004","unstructured":"P.D. Darbre, A. Aljarrah, W.R. Miller, N.G. Coldham, M.J. Sauer, G.S. Pope, Concentrations of Parabens in human breast tumours. J. Appl. Toxicol. 24(1), 5\u201313 (2004). https:\/\/doi.org\/10.1002\/jat.958.","journal-title":"J. Appl. Toxicol."},{"issue":"December 2017","key":"4230_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.mce.2018.03.014","volume":"474","author":"K Nowak","year":"2018","unstructured":"K. Nowak, W. Ratajczak-Wrona, M. G\u00f3rska, E. Jab\u0142o\u0144ska, Parabens and their effects on the endocrine system. Mol. Cell. Endocrinol. 474(December 2017), 238\u2013251 (2018). https:\/\/doi.org\/10.1016\/j.mce.2018.03.014.","journal-title":"Mol. Cell. Endocrinol."},{"issue":"EMA\/CHMP\/SWP\/27","key":"4230_CR17","first-page":"1","volume":"44","author":"European Medicines Agency","year":"2015","unstructured":"European Medicines Agency, Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use. European Union 44(EMA\/CHMP\/SWP\/272921\/2012), 1\u20133 (2015).","journal-title":"European Union"},{"issue":"5","key":"4230_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1365-2265.2009.03568.x","volume":"71","author":"C Corbetta","year":"2009","unstructured":"C. Corbetta, G. Weber, F. Cortinovis, D. Calebiro, A. Passoni, M.C. Vigone, P. Beck-Peccoz, G. Chiumello, L. Persani, A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin. Endocrinol. 71(5), 739\u2013745 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03568.x.","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"4230_CR19","doi-asserted-by":"publisher","first-page":"E338","DOI":"10.1210\/clinem\/dgaa789","volume":"106","author":"S Caiulo","year":"2021","unstructured":"S. Caiulo, C. Corbetta, M. Di Frenna, E. Medda, S. De Angelis, D. Rotondi, G. Vincenzi, T. De Filippis, M.G. Patricelli, L. Persani, G. Barera, G. Weber, A. Olivieri, M.C. Vigone, Newborn screening for congenital hypothyroidism: The benefit of using differential TSH cutoffs in a 2-screen program. J. Clin. Endocrinol. Metab. 106(1), E338\u2013E349 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa789.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4230_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3275\/8849","volume":"36","author":"A Cassio","year":"2013","unstructured":"A. Cassio, C. Corbetta, I. Antonozzi, F. Calaciura, U. Caruso, G. Cesaretti, R. Gastaldi, E. Medda, F. Mosca, E. Pasquini, M.C. Salerno, V. Stoppioni, M. Tonacchera, G. Weber, A. Olivieri, The Italian screening programfor primary congenital hypothyroidism: Actions to improve screening, diagnosis, follow-up, and surveillance. J. Endocrinological Investig. 36(3), 195\u2013203 (2013). https:\/\/doi.org\/10.3275\/8849.","journal-title":"J. Endocrinological Investig."},{"issue":"2","key":"4230_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000369394","volume":"83","author":"A Olivieri","year":"2015","unstructured":"A. Olivieri, C. Fazzini, E. Medda, Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Hormone Res. Paediatrics 83(2), 86\u201393 (2015). https:\/\/doi.org\/10.1159\/000369394.","journal-title":"Hormone Res. Paediatrics"},{"issue":"3","key":"4230_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/thy.2020.0333","volume":"31","author":"P Van Trotsenburg","year":"2021","unstructured":"P. Van Trotsenburg, A. Stoupa, J. L\u00e9ger, T. Rohrer, C. Peters, L. Fugazzola, A. Cassio, C. Heinrichs, V. Beauloye, J. Pohlenz, P. Rodien, R. Coutant, G. Szinnai, P. Murray, B. Bart\u00e9s, D. Luton, M. Salerno, L. De Sanctis, M. Vigone, H. Krude, L. Persani, M. Polak, Congenital hypothyroidism: A 2020\u20132021 consensus guidelines update\u2014an ENDO-european reference network initiative endorsed by the European Society for pediatric endocrinology and the European Society for endocrinology. Thyroid 31(3), 387\u2013419 (2021). https:\/\/doi.org\/10.1089\/thy.2020.0333.","journal-title":"Thyroid"},{"issue":"2","key":"4230_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000358198","volume":"81","author":"J L\u00e9ger","year":"2014","unstructured":"J. L\u00e9ger, A. Olivieri, M. Donaldson, T. Torresani, H. Krude, G. Van Vliet, M. Polak, G. Butler, European society for paediatric endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Hormone Res. Paediatrics 81(2), 80\u2013103 (2014). https:\/\/doi.org\/10.1159\/000358198.","journal-title":"Hormone Res. Paediatrics"},{"issue":"11","key":"4230_CR24","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1210\/jc.2013-2175","volume":"98","author":"JJ Bongers-Schokking","year":"2013","unstructured":"J.J. Bongers-Schokking, W.C.M. Resing, Y.B. De Rijke, M.A.J. De Ridder, S.M.P.F. De Muinck Keizer-Schrama, Cognitive development in congenital hypothyroidism: Is overtreatment a greater threat than undertreatment? J. Clin. Endocrinol. Metab. 98(11), 4499\u20134506 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2175.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4230_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-016-1035-1","volume":"54","author":"C Virili","year":"2016","unstructured":"C. Virili, P. Trimboli, F. Romanelli, M. Centanni, Liquid and softgel levothyroxine use in clinical practice: State of the art. Endocrine 54(1), 3\u201314 (2016). https:\/\/doi.org\/10.1007\/s12020-016-1035-1.","journal-title":"Endocrine"},{"issue":"1","key":"4230_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-018-1574-8","volume":"61","author":"I Laurent","year":"2018","unstructured":"I. Laurent, S. Tang, M. Ast\u00e8re, K.R. Wang, S. Deng, L. Xiao, Q.F. Li, Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: A meta-analysis. Endocrine 61(1), 28\u201335 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1574-8.","journal-title":"Endocrine"},{"issue":"4","key":"4230_CR27","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1210\/jc.2017-01937","volume":"103","author":"PE Aleksander","year":"2018","unstructured":"P.E. Aleksander, M. Br\u00fcckner-Spieler, A.M. Stoehr, E. Lankes, P. K\u00fchnen, D. Schnabel, A. Ernert, W. St\u00e4blein, M.E. Craig, O. Blankenstein, A. Gr\u00fcters, H. Krude, Mean high-dose l -thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 103(4), 1459\u20131469 (2018). https:\/\/doi.org\/10.1210\/jc.2017-01937.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"June","key":"4230_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.666207","volume":"12","author":"SH LaFranchi","year":"2021","unstructured":"S.H. LaFranchi, Thyroid function in preterm\/low birth weight infants: Impact on diagnosis and management of thyroid dysfunction. Front. Endocrinol. 12(June), 1\u20139 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.666207.","journal-title":"Front. Endocrinol."},{"issue":"2","key":"4230_CR29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0290","volume":"144","author":"DC Kaluarachchi","year":"2019","unstructured":"D.C. Kaluarachchi, D.B. Allen, J.C. Eickhoff, S.J. Dawe, M.W. Baker, Thyroid-stimulating hormone reference ranges for preterm infants. Pediatrics 144(2), e20190290 (2019). https:\/\/doi.org\/10.1542\/peds.2019-0290.","journal-title":"Pediatrics"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04230-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:49:06Z","timestamp":1751611746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04230-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}